ArticleInternational braz j urol : official journal of the Brazilian Society of Urology
Robot-assisted Partial Nephrectomy with the new HugoRAS System: single center matched-pair analysis.
Article in International braz j urol : official journal of the Brazilian Society of Urology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeRobotic-assisted surgery represents a leading innovation in kidney-sparing procedures across specialized urology centers. As new robotic platforms continue to emerge, comparisons with conventional laparoscopy remain necessary. This study focuses on comparing oncological, perioperative and functional outcomes of robot-assisted partial nephrectomy (RAPN) with the Hugo™ RAS system and laparoscopic partial nephrectomy (LPN) within a tertiary institution. MATERIALS AND
methodsA retrospective single-center study included 165 patients who underwent LPN (n=95) or RAPN (n=70). Perioperative clinical data, tumor characteristics, oncological and functional outcomes were obtained. Propensity score matching (1:1) was implemented to mitigate selection bias. Trifecta and pentafecta were assessed as composite surgical success endpoints. Multivariate logistic regression analyses were performed to identify the predictive factors for each.
resultsFollowing propensity score matching, 70 patients were included in each group. Operative time, WIT and estimated blood loss did not differ significantly. RAPN was associated with a shorter length of stay (3 days vs 5 days, p<0.001) without increased complication rate. Renal functional outcomes, including ≥90% eGFR preservation and CKD upstaging, were similar. Trifecta (LPN 84.3% vs. RAPN 85.7%) and pentafecta (LPN 48.6% vs. RAPN 57.4%) achievement were comparable. On multivariate analysis, higher RENAL score was the only independent predictor of trifecta failure (OR 1.410, p=0.027). For pentafecta, higher RENAL score (OR 1.396, p=0.030), older age (OR 0.929, p=0.001), and lower pre-operative eGFR (OR 0.981, p=0.049) were independent predictors of failure.
conclusionsThe study reinforced the effectiveness and safety of the new Hugo™ RAS platform for partial nephrectomy, without compromising oncological and functional success.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.